A new delivery particle developed at MIT could make mRNA vaccines more effective and potentially lower the cost per vaccine ...

A stunning new study offers early evidence that COVID-19 vaccines might have a secret superpower: a precisely timed mRNA shot could help many cancer patients live longer.

A presentation by scientists on a work group for the Centers for Disease Control and Prevention’s vaccine advisory panel ...

Pfizer Inc said on Thursday it sold a part of its stake in German drugmaker BioNTech SE , more than five years after both ...

With continued investment in mRNA research, Donald Trump could turn the stalemate against cancer into a decisive breakthrough ...

The decades-long quest to harness the power of messenger RNA to enhance cancer treatment has focused primarily on its value ...

Lung and skin cancer patients who were taking "checkpoint inhibitors" and had the COVID vaccine saw surprising results.

The study shows lung and skin cancer patients who were undergoing a type of immunotherapy and who happened to get the COVID ...

The team used the AMG1541 LNP to deliver an mRNA influenza vaccine in mice. They compared this vaccine’s effectiveness to a flu vaccine made with the lipid SM-102, which is FDA-approved and was used ...

A new lipid nanoparticle could make mRNA vaccines more effective and potentially lower the cost per dose. New research suggests an mRNA influenza vaccine delivered with the new particle could generate ...